D. Wei

发表

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Zhaohui Zheng, J. Miao, Jun Zhang, 2020, bioRxiv.

Characterization of the genome sequence of an oncolytic Newcastle disease virus strain Italien.

Bin Yang, D. Wei, H. Bian, 2008, Virus research.

UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development

Peng Lin, D. Wei, H. Bian, 2021, Signal Transduction and Targeted Therapy.

Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy

Wei Wei, D. Wei, H. Bian, 2019, Front. Cell Dev. Biol..

Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice

D. Wei, H. Bian, Zhi-Nan Chen, 2009, Liver international : official journal of the International Association for the Study of the Liver.

α2,6-linked sialic acid serves as a high-affinity receptor for cancer oncolytic virotherapy with Newcastle disease virus

D. Wei, H. Bian, Zhi-Nan Chen, 2017, Journal of Cancer Research and Clinical Oncology.

A Prospective Randomized Study Comparing Open versus Laparoscopy-Assisted D2 Radical Gastrectomy in Advanced Gastric Cancer

C. S. Zhang, D. Wei, J. Cai, 2011, Digestive Surgery.

Transmission of HIV-1 infection in newborns to mothers living with HIV in Guangdong, China

Huayun Chen, Z. Ye, Li Shuyuan, 2021 .

Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice

Y. Wang, J. Xu, Bin Wang, 2015, Journal of Experimental & Clinical Cancer Research.

Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.

B. Peeters, D. Wei, H. Bian, 2012, Human gene therapy.

HAb18G/CD147 promotes activation of hepatic stellate cells and is a target for antibody therapy of liver fibrosis.

J. Xu, Wei Zhang, Chang-sheng Chen, 2012, Journal of hepatology.

Fighting Cancer with Viruses: Oncolytic Virus Therapy in China.

J. Xu, D. Wei, H. Bian, 2017, Human gene therapy.

A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway

Y. Wang, Bin Wang, D. Wei, 2014, Clinical & Experimental Metastasis.

Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial

Zhaohui Zheng, J. Miao, A. Wen, 2021, Signal Transduction and Targeted Therapy.

Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion by Plasmodium falciparum.

Yang Zhang, P. Zhu, Kun Zhang, 2018, Blood.

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Zhaohui Zheng, J. Miao, Jun Zhang, 2020, Signal Transduction and Targeted Therapy.

CD147 overexpression promotes tumorigenicity in Chinese hamster ovary cells

D. Wei, H. Bian, Zhi-Nan Chen, 2016, Cell biology international.

Huaier Inhibits Cancer Progression Correlated with the Mutated EGFR and Other Receptor Tyrosine Kinases (c-MET/erbB-2) by Down-Regulation of Multiple Signal Transduction Pathways

Hong Lin, Ning Li, D. Wei, 2021 .

Adoptive cell transfer therapy for hepatocellular carcinoma

D. Wei, H. Bian, Zhi-Nan Chen, 2019, Frontiers of Medicine.

Construction of a minigenome rescue system for Newcastle disease virus strain Italien

D. Wei, H. Bian, Zhi-Nan Chen, 2011, Archives of Virology.

Complete Remission of the Severe Advanced Stage Cancer by miRNA-Mediated Transcriptional Control of Bcl-xL with Huaier Therapy Compared to the Conventional Chemotherapy with Platinum (II) Complex

Hong Lin, Ning Li, D. Wei, 2021 .

Huaier Induces Cancer Recovery by Rescuing Impaired Function of Transcription Control Based On the Individual Genomic Potential

Hong Lin, Ning Li, D. Wei, 2020 .

Primary primitive neuroectodermal tumor of the cervix confirmed with molecular analysis in a pregnant woman: A case report and literature review

D. Wei, P. Qu, Jianguo Zhao, 2022, Frontiers in Genetics.

Gamma‐secretase complex‐dependent intramembrane proteolysis of CD147 regulates the Notch1 signaling pathway in hepatocellular carcinoma

D. Wei, H. Bian, Zhi-Nan Chen, 2019, The Journal of pathology.

Expression of laminin and survivin in primary gallbladder carcinoma

D. Wei, 2006 .

System analysis of the regulation of the immune response by CD147 and FOXC1 in cancer cell lines

D. Wei, H. Bian, Zhi-Nan Chen, 2018, Oncotarget.

Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial

B. Xing, P. Liu, D. Wei, 2021, The Journal of Nuclear Medicine.

Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population

D. Wei, Liang Liu, Wanqiu Wang, 2021, Medicine.

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial

Ping Zhu, Gang Nan, Ronghua Xie, 2020, medRxiv.

Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation.

Yang Zhang, D. Wei, H. Bian, 2014, Journal of the National Cancer Institute.

EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling

D. Wei, H. Bian, Zhi-Nan Chen, 2021, Molecular cancer.

CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 variants

Guizhen Wu, Zhaohui Zheng, Jun Zhang, 2021, bioRxiv.

High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients

Yang Zhang, P. Zhu, Juan Tang, 2014, Breast Cancer Research and Treatment.

A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway

Bin Wang, D. Wei, Xiang-min Yang, 2014, Clinical & Experimental Metastasis.

Randomized trial of [131I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation.

Yang Zhang, D. Wei, H. Bian, 2014, Journal of the National Cancer Institute.